Characteristics of new depression diagnoses in patients with and without prior chronic opioid use

Jeffrey F. Scherrer, Joanne Salas, F. David Schneider, Kathleen K. Bucholz, Mark D. Sullivan, Laurel A. Copeland, Brian K. Ahmedani, Thomas Burroughs, Patrick J. Lustman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Chronic use (>90 Days) of opioid analgesics significantly increases the risk of development of new depression episodes (NDE). It is unclear whether depression that develops in this manner is similar to or different from NDE in persons not exposed to opioid analgesic use (OAU). Methods VA patients were classified into two groups, those who did not receive an opioid and developed depression (non-OAU+NDE, n=4314) and those that had >90 days OAU and developed NDE (OAU+NDE, n=444). OAU+NDE patients were compared to non-OAU+NDE in terms of depression severity (PHQ-9 scores), incidence of PTSD, other anxiety disorders and substance use disorders after NDE, receipt of acute phase antidepressant treatment, dual antidepressant treatment, mood stabilizers and atypical antipsychotics. Prior to computing bivariate analysis, the prevalence of pain conditions and average maximum pain scores were equalized between the two groups using propensity scores and inverse probability of treatment weighting. Results Controlling for pain, OAU+NDE patients had more depression symptoms (p=.012), more incident PTSD (p=.04) and opioid abuse/dependence and were more likely to receive 12 weeks of antidepressant treatment (p<.0001). Last, non-OAU+NDE were more likely to have incident diagnoses for any other anxiety disorder (p=.014). Conclusions Within the limitations of electronic medical record data, results indicate OAU+NDE patients have more depression symptoms, greater treatment adherence and different comorbid psychiatric conditions compared to non-OAU+NDE, independent of pain. Overall OAU related depression is as severe as non-OAU related depression and repeated depression screening in chronic opioid therapy may be warranted for pain patients, regardless of pain severity.

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalJournal of Affective Disorders
Volume210
DOIs
StatePublished - Mar 1 2017

Fingerprint

Opioid Analgesics
Depression
Analgesics
Pain
Antidepressive Agents
Post-Traumatic Stress Disorders
Anxiety Disorders
Therapeutics
Propensity Score
Electronic Health Records

Keywords

  • Depression
  • Epidemiology
  • Opioids
  • Retrospective cohort

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Characteristics of new depression diagnoses in patients with and without prior chronic opioid use. / Scherrer, Jeffrey F.; Salas, Joanne; Schneider, F. David; Bucholz, Kathleen K.; Sullivan, Mark D.; Copeland, Laurel A.; Ahmedani, Brian K.; Burroughs, Thomas; Lustman, Patrick J.

In: Journal of Affective Disorders, Vol. 210, 01.03.2017, p. 125-129.

Research output: Contribution to journalArticle

Scherrer, JF, Salas, J, Schneider, FD, Bucholz, KK, Sullivan, MD, Copeland, LA, Ahmedani, BK, Burroughs, T & Lustman, PJ 2017, 'Characteristics of new depression diagnoses in patients with and without prior chronic opioid use', Journal of Affective Disorders, vol. 210, pp. 125-129. https://doi.org/10.1016/j.jad.2016.12.027
Scherrer, Jeffrey F. ; Salas, Joanne ; Schneider, F. David ; Bucholz, Kathleen K. ; Sullivan, Mark D. ; Copeland, Laurel A. ; Ahmedani, Brian K. ; Burroughs, Thomas ; Lustman, Patrick J. / Characteristics of new depression diagnoses in patients with and without prior chronic opioid use. In: Journal of Affective Disorders. 2017 ; Vol. 210. pp. 125-129.
@article{63530d95650140fa9925fb51ab1655ab,
title = "Characteristics of new depression diagnoses in patients with and without prior chronic opioid use",
abstract = "Chronic use (>90 Days) of opioid analgesics significantly increases the risk of development of new depression episodes (NDE). It is unclear whether depression that develops in this manner is similar to or different from NDE in persons not exposed to opioid analgesic use (OAU). Methods VA patients were classified into two groups, those who did not receive an opioid and developed depression (non-OAU+NDE, n=4314) and those that had >90 days OAU and developed NDE (OAU+NDE, n=444). OAU+NDE patients were compared to non-OAU+NDE in terms of depression severity (PHQ-9 scores), incidence of PTSD, other anxiety disorders and substance use disorders after NDE, receipt of acute phase antidepressant treatment, dual antidepressant treatment, mood stabilizers and atypical antipsychotics. Prior to computing bivariate analysis, the prevalence of pain conditions and average maximum pain scores were equalized between the two groups using propensity scores and inverse probability of treatment weighting. Results Controlling for pain, OAU+NDE patients had more depression symptoms (p=.012), more incident PTSD (p=.04) and opioid abuse/dependence and were more likely to receive 12 weeks of antidepressant treatment (p<.0001). Last, non-OAU+NDE were more likely to have incident diagnoses for any other anxiety disorder (p=.014). Conclusions Within the limitations of electronic medical record data, results indicate OAU+NDE patients have more depression symptoms, greater treatment adherence and different comorbid psychiatric conditions compared to non-OAU+NDE, independent of pain. Overall OAU related depression is as severe as non-OAU related depression and repeated depression screening in chronic opioid therapy may be warranted for pain patients, regardless of pain severity.",
keywords = "Depression, Epidemiology, Opioids, Retrospective cohort",
author = "Scherrer, {Jeffrey F.} and Joanne Salas and Schneider, {F. David} and Bucholz, {Kathleen K.} and Sullivan, {Mark D.} and Copeland, {Laurel A.} and Ahmedani, {Brian K.} and Thomas Burroughs and Lustman, {Patrick J.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.jad.2016.12.027",
language = "English (US)",
volume = "210",
pages = "125--129",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Characteristics of new depression diagnoses in patients with and without prior chronic opioid use

AU - Scherrer, Jeffrey F.

AU - Salas, Joanne

AU - Schneider, F. David

AU - Bucholz, Kathleen K.

AU - Sullivan, Mark D.

AU - Copeland, Laurel A.

AU - Ahmedani, Brian K.

AU - Burroughs, Thomas

AU - Lustman, Patrick J.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Chronic use (>90 Days) of opioid analgesics significantly increases the risk of development of new depression episodes (NDE). It is unclear whether depression that develops in this manner is similar to or different from NDE in persons not exposed to opioid analgesic use (OAU). Methods VA patients were classified into two groups, those who did not receive an opioid and developed depression (non-OAU+NDE, n=4314) and those that had >90 days OAU and developed NDE (OAU+NDE, n=444). OAU+NDE patients were compared to non-OAU+NDE in terms of depression severity (PHQ-9 scores), incidence of PTSD, other anxiety disorders and substance use disorders after NDE, receipt of acute phase antidepressant treatment, dual antidepressant treatment, mood stabilizers and atypical antipsychotics. Prior to computing bivariate analysis, the prevalence of pain conditions and average maximum pain scores were equalized between the two groups using propensity scores and inverse probability of treatment weighting. Results Controlling for pain, OAU+NDE patients had more depression symptoms (p=.012), more incident PTSD (p=.04) and opioid abuse/dependence and were more likely to receive 12 weeks of antidepressant treatment (p<.0001). Last, non-OAU+NDE were more likely to have incident diagnoses for any other anxiety disorder (p=.014). Conclusions Within the limitations of electronic medical record data, results indicate OAU+NDE patients have more depression symptoms, greater treatment adherence and different comorbid psychiatric conditions compared to non-OAU+NDE, independent of pain. Overall OAU related depression is as severe as non-OAU related depression and repeated depression screening in chronic opioid therapy may be warranted for pain patients, regardless of pain severity.

AB - Chronic use (>90 Days) of opioid analgesics significantly increases the risk of development of new depression episodes (NDE). It is unclear whether depression that develops in this manner is similar to or different from NDE in persons not exposed to opioid analgesic use (OAU). Methods VA patients were classified into two groups, those who did not receive an opioid and developed depression (non-OAU+NDE, n=4314) and those that had >90 days OAU and developed NDE (OAU+NDE, n=444). OAU+NDE patients were compared to non-OAU+NDE in terms of depression severity (PHQ-9 scores), incidence of PTSD, other anxiety disorders and substance use disorders after NDE, receipt of acute phase antidepressant treatment, dual antidepressant treatment, mood stabilizers and atypical antipsychotics. Prior to computing bivariate analysis, the prevalence of pain conditions and average maximum pain scores were equalized between the two groups using propensity scores and inverse probability of treatment weighting. Results Controlling for pain, OAU+NDE patients had more depression symptoms (p=.012), more incident PTSD (p=.04) and opioid abuse/dependence and were more likely to receive 12 weeks of antidepressant treatment (p<.0001). Last, non-OAU+NDE were more likely to have incident diagnoses for any other anxiety disorder (p=.014). Conclusions Within the limitations of electronic medical record data, results indicate OAU+NDE patients have more depression symptoms, greater treatment adherence and different comorbid psychiatric conditions compared to non-OAU+NDE, independent of pain. Overall OAU related depression is as severe as non-OAU related depression and repeated depression screening in chronic opioid therapy may be warranted for pain patients, regardless of pain severity.

KW - Depression

KW - Epidemiology

KW - Opioids

KW - Retrospective cohort

UR - http://www.scopus.com/inward/record.url?scp=85008622436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008622436&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2016.12.027

DO - 10.1016/j.jad.2016.12.027

M3 - Article

C2 - 28033519

AN - SCOPUS:85008622436

VL - 210

SP - 125

EP - 129

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -